- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04919408
Evaluation of the Incidence of Chronic Post-cesarean Pain as Part of an Enhanced Recovery After Surgery (ERAS) Protocol. (ChroCéRAAC)
Enhanced Rehabilitation After Surgery (ERAS), developed in the 1990s, is a program encompassing a set of measures before, during and after surgery aimed at improving management by promoting the early recovery of the patient's abilities after surgery.
The ERAS has been scientifically validated and standardized in many surgical disciplines since the implementation of guidelines in France in 2016.
Regarding the obstetrical field, it was not until 2018 that the caesarean section could benefit from ERAS, with the publication of specific guidelines.
Several studies have been able to demonstrate ERAS effectiveness in reducing the length of hospitalization, postoperative complications, the consumption of analgesics immediately after surgery, and the financial cost, including in the context of cesarean sections.
But beyond immediate benefit, the impact of an ERAS protocol on chronic pain has not yet been evaluated.
Chronic pain is defined as physical discomfort that persists for more than 2 months after surgery.
It was not until 2004 that research focused on chronic post-cesarean pain, finding an incidence of chronic pain of 18.6% at 3 months and 12.3% at 6 months. In 2016, another study estimated an incidence of chronic pain in the caesarean scar at 15% at 3 months and 11% at 1 year. The investigators can notice that the presence of chronic post-cesarean pain remained stable over this period.
Several risk factors have been identified, such as the presence of acute pain immediately after surgery, the type of anesthesia, the type of surgical incision or a significant state of anxiety before the operation.
In this context, the investigators wish to assess the rate of chronic post-surgical pain in scheduled cesarean sections (excluding emergencies) under spinal anesthesia as part of a ERAS protocol. The investigatrors will also specify the type of pain and its impact on the daily activities of young mothers and will assess the level of adherence of medical and paramedical teams to the ERAS protocol.
To answer these questions, the investigators will conduct a telephone survey with a questionnaire to assess pain at 3 months and then 6 months after their cesarean section. The pain studied is defined as being the pain at the level of the caesarean scar.
This is an innovative subject evaluating the impact of the implementation of an ERAS protocol on chronic pain. Depending on the results, the investigators will be able to optimize the prevention of chronic pain of cesarean section.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Enhanced Rehabilitation After Surgery (ERAS), developed in the 1990s, is a program encompassing a set of measures before, during and after surgery aimed at improving management by promoting the early recovery of the patient's abilities after surgery.
The ERAS has been scientifically validated and is currently standardized in many surgical disciplines since the implementation of guidelines in France in 2016.
Regarding the obstetrical field, it was not until 2018 that the caesarean section could benefit from ERAS, with the publication of specific guidelines.
Several studies have been able to demonstrate ERAS effectiveness in reducing the length of hospitalization, postoperative complications, the consumption of analgesics immediately after surgery, and the financial cost, including in the context of cesarean sections.
But beyond immediate benefit, the impact of an ERAS protocol on chronic pain has not yet been evaluated.
Chronic pain is defined as physical discomfort that persists for more than 2 months after surgery.
It was not until 2004 that research focused on chronic post-cesarean pain, finding an incidence of chronic pain of 18.6% at 3 months and 12.3% at 6 months. In 2016, another study estimated an incidence of chronic pain in the caesarean scar at 15% at 3 months and 11% at 1 year. The investigators can notice that the presence of chronic post-cesarean pain remained stable over this period.
Several risk factors have been identified, such as the presence of acute pain immediately after surgery, the type of anesthesia, the type of surgical incision or a significant state of anxiety before the operation.
In this context, the investigators wish to assess the rate of chronic post-surgical pain in scheduled cesarean sections (excluding emergencies) under spinal anesthesia as part of a ERAS protocol. The investigatrors will also specify the type of pain and its impact on the daily activities of young mothers and will assess the level of adherence of medical and paramedical teams to the ERAS protocol.
To answer these questions, the investigators will conduct a telephone survey with a questionnaire to assess pain at 3 months and then 6 months after their cesarean section. The pain studied is defined as being the pain at the level of the caesarean scar.
This is an innovative subject evaluating the impact of the implementation of an ERAS protocol on chronic pain. Depending on the results, the investigators will be able to optimize the prevention of chronic pain of cesarean section.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Toulon, France, 83056
- Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
-
-
Bouches-du-Rhône
-
Marseille, Bouches-du-Rhône, France, 13915
- Hopital Nord
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients scheduled for cesarean section under spinal anesthesia
- Patients ASA I and II according to The ASA Physical Status Classification System
Exclusion Criteria:
intervention under general anesthesia
- complication during the operation
- post-partum haemorrrhage
- pre-op anemia <9g / dl
- Patient under judicial protection (guardianship, curatorship...) or safeguard of justice.
- Patient unable to answer the questionnaires by telephone (not speaking French, hard of hearing, mute French language, hearing impaired, mute...)
- Any other reason that, in the opinion of the investigator, could interfere with the evaluation of the objectives of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patients scheduled for cesarean section under spinal anesthesia
Patients scheduled for cesarean section under spinal anesthesia ASA I and II according to The ASA Physical Status Classification System
|
telephone survey with a questionnaire to assess pain at 3 months and then 6 months after their cesarean section
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To study the incidence of chronic post-surgical pain in scheduled cesarean section under spinal anesthesia as part of a ERAS protocol.
Time Frame: 3 months
|
The importance of the pain will be assessed using a verbal scale made up of the items : absent, minimal, moderate and severe. The incidence rate at 3 months will be calculated as follows: Number of patients with minimal, moderate or severe scar pain 3 months after their cesarean section / Number of patients evaluable at 3 months |
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To study the incidence of chronic post-surgical pain in scheduled cesarean section under spinal anesthesia as part of a ERAS protocol.
Time Frame: 6 months
|
The importance of the pain will be assessed using a verbal scale made up of the items : absent, minimal, moderate and severe. The incidence rate at 6 months will be calculated as follows: Number of patients with minimal, moderate or severe scar pain 6 months after their cesarean section / Number of patients evaluable at 6 months |
6 months
|
|
Specify the type and extent of the pain
Time Frame: 6 months
|
The type and extent of the pain will be assessed using a verbal scale adapted from the questionnaire used in the study by L. Nikolajsen et al(1), and the DN4 questionnaire to search for neuropathic pain.
|
6 months
|
|
Evaluate the chronical pain impact on daily activities of young mothers
Time Frame: 6 months
|
The chronical pain impact on daily activities of young mothers will be assessed using a verbal scale adapted from the questionnaire used in the study by L. Nikolajsen et al(1)
|
6 months
|
|
Evaluate the rate of adherence to the ERAS protocol.
Time Frame: 24 months
|
As the anesthesiology department is affiliated with the French ERAS society : GRACE (French-speaking group for improved rehabilitation after surgery), we will use their audit tool to assess the rate of adherence to ERAS protocol.
|
24 months
|
Collaborators and Investigators
Investigators
- Study Director: Géraldine SLEHOFER-LHERIAU, MD, Anesthesiology department Hôpital Sainte Musse
Publications and helpful links
General Publications
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-CHITS-003
- 2021-A00397-34 (Other Identifier: IdRCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Post-cesarean Pain
-
Menoufia UniversityCompleted
-
E-DA HospitalNot yet recruitingCesarean Section | Post Operative Pain, Acute | Post Operative Pain, ChronicTaiwan
-
Consorci Sanitari de TerrassaRecruitingChronic Pain | Cesarean Section Complications | Chronic Post Surgical PainSpain
-
Yale UniversityCompletedCesarean Section Complications | Post-Cesarean PainUnited States
-
University of LahoreCompletedPost Cesarean Section Patient | Chronic Low Back Pain (CLBP)Pakistan
-
Dalin Tzu Chi General HospitalRecruitingCesarean Section | Postsurgical Pain | Chronic Post-surgical PainTaiwan
-
Ohio State UniversityTrueRelief, LLCCompleted
-
Cairo UniversityUnknownPost Cesarean Section Pain
-
HaEmek Medical Center, IsraelCompleted
-
Tufts Medical CenterCompletedCesarean Section Complications | Post-operative Pain | Post-partum PainUnited States
Clinical Trials on telephone survey
-
The University of Hong KongUnknown
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSarcoma | Breast Carcinoma | Head and Neck CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)UnknownAdvanced CancersUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Cervical Cancer | Breast Cancer | Hodgkin's DiseaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
Fred Hutchinson Cancer CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingObesity-Related Malignant NeoplasmUnited States
-
University Hospital, AngersCompletedAnaphylaxis Caused by Hymenoptera Venom (Disorder)France
-
Memorial Sloan Kettering Cancer CenterVanderbilt University; Beth Israel Medical CenterCompletedBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Lung Cancer | Prostate CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterJohns Hopkins University; Memorial Sloan Kettering Cancer Center; United States... and other collaboratorsCompletedMetastatic Castrate-Resistant Prostate CancerUnited States
-
Stanford UniversityNational Cancer Institute (NCI)CompletedCervical Cancer | Endometrial Cancer | Radiation Toxicity | Vaginal CancerUnited States